Loading...
Back to narrative

AnalystConsensusTarget updated the narrative for SDR

Update shared on 23 Oct 2025

Fair value Increased 1.21%
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
20.9%
7D
-1.2%

Analysts have increased their price target for Schroders, reflecting a modest upward revision supported by improved profit margin projections and slightly reduced risk assumptions. The target has risen by approximately £0.05 based on updated fair value assessments.

Analyst Commentary

Recent updates from market observers highlight both optimism and caution regarding Schroders' outlook. This is reflected in a series of revised price targets and changes in analyst ratings.

Bullish Takeaways

  • Bullish analysts have increased their price targets for Schroders, signaling growing confidence in its earnings potential and fair value trajectory.
  • Recent upgrades to a Buy rating and higher target prices are being justified on the basis of improved valuations following share price weakness. This suggests the stock may represent attractive value at current levels.
  • Modest upward revisions to profit margin assumptions support the positive sentiment around Schroders' operational efficiency and future profitability.
  • Continued resilience despite sector challenges indicates that analysts see Schroders as well-positioned to capitalize on further growth opportunities.

Bearish Takeaways

  • Some analysts are maintaining Neutral or Underweight stances, expressing caution about immediate upside potential despite price target increases.
  • Concerns linger regarding the pace of earnings growth and execution risks, particularly in a more competitive and uncertain market environment.
  • Cautious adjustments to risk assumptions indicate that while near-term fundamentals have improved modestly, broader challenges to valuation sustainability remain top of mind for less bullish observers.

What's in the News

  • JPMorgan raised Schroders' price target to 1,690 GBp from 1,670 GBp and maintained a Neutral rating on the shares (Periodical).
  • Schroders has approved an additional GBP 70 million for co-investment and seed into Schroders Capital, supporting growth in private assets (Key Development).
  • An extra GBP 200 million in seed funding has been allocated to public market launches of innovative product strategies (Key Development).
  • The company continues to consider acquisitions in adviser networks as well as selective inorganic opportunities within its Wealth business (Key Development).

Valuation Changes

  • Fair Value: Increased slightly to £4.08 from £4.03, indicating a modest upward revision in Schroders' assessed worth.
  • Discount Rate: Decreased marginally to 8.48 percent from 8.57 percent, which reflects a slightly lower perceived risk profile.
  • Revenue Growth: The projected contraction has lessened, with revenue now expected to decline by 5.28 percent compared to a previous estimate of 5.83 percent.
  • Net Profit Margin: Improved marginally to 24.50 percent from 24.46 percent, indicating a small gain in expected profitability.
  • Future P/E: Declined slightly to 13.24x from 13.36x, suggesting a modest reduction in the multiple at which the company's earnings are valued.

Have other thoughts on Schroders?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.